U.S. Markets close in 12 mins
  • S&P 500

    3,629.89
    -5.52 (-0.15%)
     
  • Dow 30

    29,867.57
    -178.67 (-0.59%)
     
  • Nasdaq

    12,096.62
    +59.83 (+0.50%)
     
  • Russell 2000

    1,846.72
    -6.82 (-0.37%)
     
  • Crude Oil

    45.66
    +0.75 (+1.67%)
     
  • Gold

    1,805.00
    +0.40 (+0.02%)
     
  • Silver

    23.38
    +0.08 (+0.34%)
     
  • EUR/USD

    1.1925
    +0.0028 (+0.2385%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.17
    -0.47 (-2.17%)
     
  • GBP/USD

    1.3387
    +0.0029 (+0.2169%)
     
  • USD/JPY

    104.4200
    -0.0600 (-0.0574%)
     
  • BTC-USD

    18,811.51
    -229.32 (-1.20%)
     
  • CMC Crypto 200

    370.90
    +0.38 (+0.10%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

FTI Consulting (FCN) Surges: Stock Moves 7.1% Higher

Zacks Equity Research
·2 min read

FTI Consulting, Inc. FCN was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $101.93–$125.32 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen one negative estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

FTI Consulting has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.


 

A better-ranked stock in the Consulting Services industry is PageGroup plc
MPGPF, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
FTI Consulting, Inc. (FCN) : Free Stock Analysis Report
 
PAGEGROUP PLC (MPGPF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.